On October 25, 2025, Health Canada granted conditional authorization for lecanemab, marketed as Leqembi, marking the first disease-modifying therapy approved in the country for early-stage Alzheimer's disease.
Smoking remains one of the leading preventable causes of death worldwide, claiming millions of lives each year through diseases like cancer, heart disease, and chronic obstructive pulmonary disease (COPD). Despite the well-known risks, many people...
Dementia, particularly Alzheimer's disease, is a major health concern for aging populations in the U.S., with limited treatment options making prevention essential. While factors like diabetes, high blood pressure, and inactivity contribute to risk
Diabetes significantly impacts eye health, making diligent blood sugar management essential for preserving clear vision. People with diabetes are at a heightened risk for several eye conditions
Did you know that a drop in your physical activity could be an early warning sign of heart disease—up to 12 years before any symptoms appear? A groundbreaking study reveals that staying active throughout adulthood...
Across Canada, personal tales of healthcare frustrations abound—from endless searches for a family physician to being denied entry at overcrowded walk-in clinics, or enduring agonizing delays of months or years for life-altering surgeries.
Danish pharmaceutical giant Novo Nordisk has intensified its legal battle against the sale of unapproved versions of semaglutide, the key ingredient in its blockbuster weight-loss and diabetes drugs
As Canadian pharmacies embrace a digital transformation—offering virtual consultations, online prescription renewals, and cloud-based management systems—new opportunities for efficiency and accessibility have emerged.
Whether you're managing prediabetes, living with diabetes, or simply aiming to optimize your health, regulating blood sugar is a common goal. Fortunately, you can achieve this without giving up your favorite foods or relying solely...
A groundbreaking study, published in the New England Journal of Medicine and led by Dr. Jiwon Oh, a neurologist and scientist at St. Michael’s Hospital, part of Unity Health Toronto, reveals that a new drug,...
